The effect of povidone-iodine rectal cleansing on post-biopsy infectious complications

References

• Liss MA, Ehdaie B, Loeb S, et al. An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol. 2017;198(2):329–334.
   PubMed Web of Science ®Google Scholar
• Pilatz A, Dimitropoulos K, Veeratterapillay R, et al. Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J Urol. 2020;204(2):224–230.
   PubMed Web of Science ®Google Scholar
• Yang L, Tang Z, Gao L, et al. The augmented prophylactic antibiotic could be more efficacious in patients undergoing transrectal prostate biopsy: a systematic review and meta-analysis. Int Urol Nephrol. 2016; 48(8):1197–1207.
   PubMed Web of Science ®Google Scholar
• Taylor AK, Zembower TR, Nadler RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol. 2012;187(4):1275–1279.
   PubMed Web of Science ®Google Scholar
• Brown LC, Ahmed HU, Faria R, et al. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Health Technol Assess. 2018;22(39):1–176.
   Web of Science ®Google Scholar
• Pepdjonovic L, Tan GH, Huang S, et al. Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis. World J Urol. 2017;35(8):1199–1203.
   PubMed Web of Science ®Google Scholar
• Jeon SS, Woo SH, Hyun JH, et al. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology. 2003;62(3):461–466.
   PubMed Web of Science ®Google Scholar
• Issa MM, Al-Qassab UA, Hall J, et al. Formalin disinfection of biopsy needle minimizes the risk of sepsis following prostate biopsy. J Urol. 2013;190(5):1769–1775.
   PubMed Web of Science ®Google Scholar
• Ryu JW, Jung SI, Ahn JH, et al. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications. Int Urol Nephrol. 2016;48(11):1763–1770.
   PubMed Web of Science ®Google Scholar
• Liss MA, Johnson JR, Porter SB, et al. Clinical and microbiological determinants of infection after transrectal prostate biopsy. Clin Infect Dis. 2015;60(7):979–987.
   PubMed Web of Science ®Google Scholar
• Mottet N, Cornford P, van den Bergh RCN, et al. EAU ESTRO ESUR SIOG guidelines on prostate cancer. Edn. 136 Presented at the EAU Annual Congress Milan, 2021.
   Google Scholar
• Park DS, Oh JJ, Lee JH, et al. Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy. Adv Urol. 2009;2009:750598.
   PubMedGoogle Scholar
• Gyorfi JR, Otteni C, Brown K, et al. Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate. World J Urol. 2014;32(4):905–909.
   PubMed Web of Science ®Google Scholar
• Huang YC, Ho DR, Wu CF, et al. Modified bowel preparation to reduce infection after prostate biopsy. Chang Gung Med J. 2006;29(4):395–400.
   PubMedGoogle Scholar
• Gil-Vernet Sedo JM, Alvarez-Vijande García R. Effect of intrarectal povidone-iodine in the incidence of infectious complications after transrectal prostatic biopsy. Arch Esp Urol. 2012; May65(4):463–466.
   PubMed Web of Science ®Google Scholar
• Abughosh Z, Margolick J, Goldenberg SL, et al. A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol. 2013;189(4):1326–1331.
   PubMed Web of Science ®Google Scholar
• Park R, Gyorfi J, Dewan K, et al. Topical rectal antiseptic at time of prostate biopsy: how a resident patient safety project has evolved into institutional practice. Int Urol Nephrol. 2018;50(9):1563–1568.
   PubMed Web of Science ®Google Scholar
• Lee JE, Shin SS, Kang TW, et al. Comparison of different rectal cleansing methods for reducing post-procedural infectious complications after transrectal ultrasound-guided prostate biopsy. Urol J. 2020;17(1):36–41.
   PubMed Web of Science ®Google Scholar
• Ramedani S, Clark JY, Knoedler JJ, et al. Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship. Prostate Int. 2021;9(4):185–189.
   PubMed Web of Science ®Google Scholar
• Williamson DA, Barrett LK, Rogers BA, et al. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis. 2013;57(2):267–274.
   PubMed Web of Science ®Google Scholar
• Roberts MJ, Williamson DA, Hadway P, et al. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. Int J Antimicrob Agents. 2014;43(4):301–309.
   PubMed Web of Science ®Google Scholar
• Carignan A, Roussy J-F, Lapointe V, et al. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol. 2012;62(3):453–459.
   PubMed Web of Science ®Google Scholar
• McArdle CS, Morran CG, Pettit L, et al. Value of oral antibiotic prophylaxis in colorectal surgery. Br J Surg. 1995;82(8):1046–1048.
   PubMed Web of Science ®Google Scholar
• Scott S, Harris PN, Williamson DA, et al. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis. World J Urol. 2018;36(7):1007–1017.
   PubMed Web of Science ®Google Scholar
• Cussans A, Somani BK, Basarab A, et al. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int. 2016;117(5):725–731.
   PubMed Web of Science ®Google Scholar
• Jiang P, Liss MA, Szabo RJ. Targeted antimicrobial prophylaxis does not always prevent sepsis after transrectal prostate biopsy. J Urol. 2018;200(2):361–368.
   PubMed Web of Science ®Google Scholar
• Hadjipavlou M, Eragat M, Kenny C, et al. Effect of augmented antimicrobial prophylaxis and rectal swab culture-guided targeted prophylaxis on the risk of sepsis following transrectal prostate biopsy. Eur Urol Focus. 2020;6(1):95–101.
   PubMedGoogle Scholar
• Jacewicz M, Günzel K, Rud E, et al. Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal 148 prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial. Lancet Infect Dis. 2022;3099(22):00373–00375.
   Google Scholar
• Ouzzane A, Puech P, Lemaitre L, et al. Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. Urology. 2011;78(6):1356–1362.
   PubMed Web of Science ®Google Scholar
• Valerio M, Donaldson I, Emberton M, et al. Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol. 2015;68(1):8–19.
   PubMed Web of Science ®Google Scholar